Production (Stage)
KORU Medical Systems, Inc.
KRMD
$2.66
-$0.06-2.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.53% | 23.00% | 16.80% | 21.54% | 10.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.53% | 23.00% | 16.80% | 21.54% | 10.89% |
| Cost of Revenue | 15.97% | 14.74% | 12.51% | -3.20% | -4.66% |
| Gross Profit | 18.48% | 28.44% | 19.43% | 40.94% | 23.06% |
| SG&A Expenses | 11.23% | 16.24% | 10.90% | 0.31% | -1.26% |
| Depreciation & Amortization | -6.05% | -7.36% | 5.46% | 2.35% | 8.59% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.10% | 11.13% | 12.38% | -5.30% | -2.78% |
| Operating Income | 36.52% | 27.67% | 4.90% | 63.03% | 35.83% |
| Income Before Tax | 39.76% | 22.89% | 5.26% | 68.06% | 35.21% |
| Income Tax Expenses | -- | -99.95% | -- | -- | -- |
| Earnings from Continuing Operations | 39.76% | 79.09% | -15.53% | 60.39% | 19.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.76% | 79.09% | -15.53% | 60.39% | 19.70% |
| EBIT | 36.52% | 27.67% | 4.90% | 63.03% | 35.83% |
| EBITDA | 40.60% | 24.15% | 6.32% | 67.65% | 39.16% |
| EPS Basic | 40.09% | 79.14% | -15.00% | 60.51% | 20.00% |
| Normalized Basic EPS | 40.00% | 24.19% | 5.70% | 68.16% | 34.24% |
| EPS Diluted | 40.09% | 79.14% | -15.00% | 60.51% | 20.00% |
| Normalized Diluted EPS | 40.00% | 24.19% | 5.70% | 68.16% | 34.24% |
| Average Basic Shares Outstanding | 0.59% | 0.36% | 0.46% | 0.45% | 0.49% |
| Average Diluted Shares Outstanding | 0.59% | 0.36% | 0.46% | 0.45% | 0.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |